Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-12 of 12 for your search:
Drug:
soy protein isolate
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy
Phase:
Phase IV
Type:
Supportive care
Status:
Completed
Age:
21 and over
Sponsor:
NCI, Other
Protocol IDs:
04-08-09-04
, NCT00245518
2.
Phase III Randomized Study of the Effect of a Diet Low in Fat and High in Soy, Fruits, Vegetables, Green Tea, Vitamin E, and Fiber on PSA Levels in Patients With Prostate Cancer (Summary Last Modified 04/2002)
Phase:
Phase III
Type:
Prevention, Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-98014
, NCI-G98-1445, NCT00003367
3.
Phase III Randomized Study of Vitamin E, Selenium, and Soy Protein Isolate in Patients With High-Grade Prostatic Intraepithelial Neoplasia
Phase:
Phase III
Type:
Prevention
Status:
Closed
Age:
Not specified
Sponsor:
Other
Protocol IDs:
CAN-NCIC-PRP1
, NCT00064194, PRP1
4.
Phase II Trial of Dietary Fatty Acids: Roles in Hormonally Mediated Cancers in Normal Premenopausal Women (Summary Last Modified 06/98)
Phase:
Phase II
Type:
Prevention
Status:
Closed
Age:
18-35
Sponsor:
NCI
Protocol IDs:
UMN-9509M10234
, NCI-P97-0108
5.
Phase II Randomized Study of Soy Protein in Postmenopausal Women With Breast Disease Taking Tamoxifen and Experiencing Hot Flashes
Phase:
Phase II
Type:
Supportive care
Status:
Closed
Age:
Postmenopausal (20 and over)
Sponsor:
NCI
Protocol IDs:
CALGB-79805
, NCI-P02-0206, NCT00031720
6.
Phase II Randomized Study of Dietary Soy in Patients With Elevated PSA Levels
Phase:
Phase II
Type:
Prevention
Status:
Completed
Age:
50 and over
Sponsor:
NCI
Protocol IDs:
CALGB-79806
, NCI-P02-0207, NCT00031746
7.
Phase II Randomized Study of Soy Protein Isolate (Isoflavones) and Radiotherapy in Patients With Localized Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
WSU-D-2325
, NCT00243048
8.
Phase II Randomized Study of Neoadjuvant Dietary Supplementation With Soy in Patients Undergoing Radical Prostatectomy for Localized Prostate Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Closed
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
CCCWFU-98203
, CCCWFU-98203, CCCWFU-BG03-332, NCT00345813
9.
Phase I Randomized Study of Genistein for Prevention of Cancer in Patients With No History of Cancer or With Asymptomatic Early Prostate Cancer or Other Malignancy
Phase:
Phase I
Type:
Prevention, Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-98-C-0099B
10.
Dietary Intervention Study of Low-Fat Diet, Fish Oil, and Soy Supplements in Breast Cancer Patients
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
UCLA-HSPC-9508339
, NCI-V96-0940
11.
Pilot Randomized Study of Soy Protein Isolate (Isoflavones) in Women Planning to Undergo Mastectomy or Lumpectomy for Breast Cancer
Phase:
No phase specified
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MCC-0104
, NCI-5348, NCI-P02-0214, NCT00036686
12.
Pilot Study of Soy-Based Meal Replacement (AlmasedĀ®) as a Weight Loss Intervention in Patients With Estrogen Receptor/Progesterone Receptor-Negative Stage I-III Breast Cancer in Complete Remission
Phase:
No phase specified
Type:
Behavioral study, Educational/Counseling/Training, Supportive care
Status:
Closed
Age:
21 and over
Sponsor:
NCI
Protocol IDs:
CCCWFU-98904
, NCT00343434
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute